{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:41:24Z","timestamp":1784655684007,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX003025"],"award-info":[{"award-number":["BX003025"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bonr.2022.101174","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T13:12:43Z","timestamp":1644239563000},"page":"101174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cortical porosity is elevated after a single dose of zoledronate in two rodent models of chronic kidney disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Elizabeth A.","family":"Swallow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne E.","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha P.","family":"Tippen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bonr.2022.101174_bb0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bonr.2022.101174_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1138\/20060248","article-title":"Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone","volume":"4","author":"Allen","year":"2007","journal-title":"BoneKEy-Osteovision"},{"issue":"1","key":"10.1016\/j.bonr.2022.101174_bb0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2010.07.011","article-title":"Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bonr.2022.101174_bb0020","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00198-012-2103-x","article-title":"Skeletal effects of zoledronic acid in an animal model of chronic kidney disease","volume":"24","author":"Allen","year":"2013","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bonr.2022.101174_bb0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00198-014-2978-9","article-title":"Changes in skeletal collagen crosslinks and matrix hydration in high and low turnover chronic kidney disease","volume":"26","author":"Allen","year":"2015","journal-title":"Osteoporos. Int."},{"issue":"12","key":"10.1016\/j.bonr.2022.101174_bb0030","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1007\/s00198-016-3701-9","article-title":"Zoledronate treatment has different effects in mouse strains with contrasting baseline bone mechanical phenotypes","volume":"27","author":"Aref","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"23","key":"10.1016\/j.bonr.2022.101174_bb0540","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"J. Am. Med. Assoc."},{"issue":"4","key":"10.1016\/j.bonr.2022.101174_bb0575","first-page":"510","article-title":"Treatment of reduced bone density with ibandronate in dialysis patients","volume":"21","author":"Bergner","year":"2008","journal-title":"J. Nephrol."},{"issue":"6","key":"10.1016\/j.bonr.2022.101174_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0130504","article-title":"Structural and mechanical improvements to bone are strain dependent with axial compression of the tibia in female C57BL\/6 mice","volume":"10","author":"Berman","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bonr.2022.101174_bb0050","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bonr.2022.101174_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4412","article-title":"Changes in the US burden of chronic kidney disease from 2002 to 2016: an analysis of the global burden of disease study","volume":"1","author":"Bowe","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"May","key":"10.1016\/j.bonr.2022.101174_bb0060","article-title":"Fifty years of bisphosphonates: what are their mechanical effects on bone?","volume":"138","author":"Burr","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2022.101174_bb0065","series-title":"Skeletal Aging and Osteoporosis","article-title":"Bisphosphonates and PTH for preventing fractures","author":"Burr","year":"2012"},{"key":"10.1016\/j.bonr.2022.101174_bb0070","series-title":"Chronic Kidney Disease in the United States, 2021","author":"Center for Disease Control and Prevention","year":"2021"},{"issue":"3","key":"10.1016\/j.bonr.2022.101174_bb0075","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jbmr.3925","article-title":"Effect of advanced glycation end-products (AGE) lowering drug ALT-711 on biochemical, vascular, and bone pers in a rat model of CKD-MBD","volume":"35","author":"Chen","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bonr.2022.101174_bb0080","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bonr.2022.101174_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bone.2011.02.011","article-title":"Bisphosphonates for postmenopausal osteoporosis","volume":"49","author":"Eastell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2022.101174_bb0530","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","article-title":"Renal function and risk of hip and vertebral fractures in older women","volume":"167","author":"Ensrud","year":"2007","journal-title":"Arch. Intern. Med."},{"issue":"9","key":"10.1016\/j.bonr.2022.101174_bb0095","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00198-008-0602-6","article-title":"Strontium ranelate does not stimulate bone formation in ovariectomized rats","volume":"19","author":"Fuchs","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bonr.2022.101174_bb0510","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bone.2011.03.672","article-title":"Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease","volume":"48","author":"Iwasaki","year":"2011","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bonr.2022.101174_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bone.2013.07.037","article-title":"Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease","volume":"57","author":"Iwasaki","year":"2013","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bonr.2022.101174_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ki.2008.180","article-title":"Treatment of experimental renal osteodystrophy with pamidronate","volume":"74","author":"Jokihaara","year":"2008","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bonr.2022.101174_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bonr.2022.101174_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbm4.10473","article-title":"The effect of single versus group \u03bcCT on the detection of trabecular and cortical disease phenotypes in mouse bones","volume":"5","author":"Kohler","year":"2021","journal-title":"JBMR Plus"},{"issue":"6","key":"10.1016\/j.bonr.2022.101174_bb0515","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2008.646","article-title":"Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure","volume":"75","author":"Lomashvili","year":"2009","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.bonr.2022.101174_bb0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrneph.2013.198","article-title":"Evaluating bone quality in patients with chronic kidney disease","volume":"9","author":"Malluche","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"issue":"April","key":"10.1016\/j.bonr.2022.101174_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bone.2019.05.002","article-title":"Time course of rapid bone loss and cortical porosity formation observed by longitudinal \u03bcCT in a rat model of CKD","volume":"125","author":"Mcnerny","year":"2019","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bonr.2022.101174_bb0140","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00223-019-00642-w","article-title":"Elevations in cortical porosity occur prior to significant rise in serum parathyroid hormone in young female mice with adenine-induced CKD","volume":"106","author":"Metzger","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2022.101174_bb0145","article-title":"Reversing cortical porosity: cortical pore infilling in preclinical models of chronic kidney disease","author":"Metzger","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2022.101174_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115963","article-title":"Strain-specific alterations in the skeletal response to adenine-induced chronic kidney disease are associated with differences in parathyroid hormone levels","volume":"148","author":"Metzger","year":"2021","journal-title":"Bone"},{"issue":"4 April","key":"10.1016\/j.bonr.2022.101174_bb0155","first-page":"1","article-title":"Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL\/6 mice with more severe deficits in cortical bone properties of male mice","volume":"16","author":"Metzger","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bonr.2022.101174_bb0525","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in patients with CKD: time for action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bonr.2022.101174_bb0165","first-page":"176","article-title":"A rat model of chronic kidney disease-mineral bone disorder (CKD-BMD) and the effect of dietary protein source","volume":"75","author":"Moe","year":"2009","journal-title":"Vascular"},{"issue":"11","key":"10.1016\/j.bonr.2022.101174_bb0170","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/jbmr.485","article-title":"The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat","volume":"26","author":"Moe","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bonr.2022.101174_bb0175","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/jbmr.2089","article-title":"A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD","volume":"29","author":"Moe","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bonr.2022.101174_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0099262","article-title":"Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease","volume":"9","author":"Newman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bonr.2022.101174_bb0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2015.04.021","article-title":"Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions","volume":"77","author":"Newman","year":"2015","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bonr.2022.101174_bb0190","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.bonr.2022.101174_bb0520","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2008.264","article-title":"Chronic kidney disease and bone fracture: a rowing concern","volume":"74","author":"Nickolas","year":"2008","journal-title":"Kidney Int."},{"issue":"September 2013","key":"10.1016\/j.bonr.2022.101174_bb0200","first-page":"1","article-title":"Bisphosphonates and bone quality","volume":"3","author":"Pazianas","year":"2014","journal-title":"Bonekey Rep."},{"issue":"6","key":"10.1016\/j.bonr.2022.101174_bb0205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bonr.2022.101174_bb0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0021-9290(88)90186-8","article-title":"Stiffness of compact bone: effects of porosity and density","volume":"21","author":"Schaffler","year":"1988","journal-title":"J. Biomech."},{"issue":"9","key":"10.1016\/j.bonr.2022.101174_bb0215","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00198-018-4589-3","article-title":"Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease","volume":"29","author":"Swallow","year":"2018","journal-title":"Osteoporos. Int."},{"issue":"July","key":"10.1016\/j.bonr.2022.101174_bb0220","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bone.2019.07.007","article-title":"Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing","volume":"127","author":"Swallow","year":"2019","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bonr.2022.101174_bb0225","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bonr.2022.101174_bb0570","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ajkd.2009.12.039","article-title":"Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial","volume":"56","author":"Toussaint","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bonr.2022.101174_bb0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s001980200000","article-title":"Biomechanics of bone: determinants of skeletal fragility and bone quality","volume":"13","author":"Turner","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2022.101174_bb0240","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone : a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bonr.2022.101174_bb0245","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1359\/jbmr.081259","article-title":"Inbred strain-specific response to biglycan deficiency in the cortical bone of C57BL6\/129 and C3H\/He mice","volume":"24","author":"Wallace","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bonr.2022.101174_bb0250","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/M16-2752","article-title":"Benefits and harms of osteoporosis medications in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"166","author":"Wilson","year":"2017","journal-title":"Ann. Intern. Med."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187222000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187222000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:24:13Z","timestamp":1762446253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187222000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":50,"alternative-id":["S2352187222000092"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2022.101174","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortical porosity is elevated after a single dose of zoledronate in two rodent models of chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2022.101174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101174"}}